Ghanab
0806.912.118 · rovalta.com · 23/09/2026
Ghanab
Overview
What does Ghanab do?
Ghanab is a Private limited company incorporated in 2008. Its main activity is: Specialist medical practice activities. Its registered office is in Oudenaarde.
9700 Oudenaarde · FlandreSee on map
Trend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||
| Gross margin | 755,9 k € | +27.6% | 592,5 k € | +1.6% | 583,5 k € | +27.9% | 456,2 k € | +7.8% | 423,2 k € | +3.0% | 411 k € | +2.3% | 401,7 k € | +0.7% | 399 k € | -21.9% | 511,2 k € | -14.3% | 596,4 k € | +8.3% | 550,7 k € | -5.1% | 580,5 k € | +4.6% | 555,2 k € | +12.9% | 491,7 k € | +216% | 155,5 k € | +1.2% | 153,6 k € | +2.8% | 149,4 k € |
| EBITDA | 751,3 k € | +27.9% | 587,5 k € | +2.2% | 574,8 k € | +26.9% | 453 k € | +7.7% | 420,5 k € | +3.0% | 408,1 k € | +3.0% | 396,2 k € | +0.2% | 395,2 k € | -22.1% | 507,3 k € | -14.4% | 592,9 k € | +8.3% | 547,4 k € | -5.1% | 577 k € | +4.6% | 551,5 k € | +13.2% | 487 k € | +218% | 153,2 k € | +2.6% | 149,3 k € | +1.0% | 147,9 k € |
| Operating result | 576,3 k € | +27.6% | 451,5 k € | -3.7% | 468,8 k € | +32.3% | 354,5 k € | +37.3% | 258,2 k € | +18.7% | 217,5 k € | -14.2% | 253,7 k € | +0.8% | 251,6 k € | -28.0% | 349,3 k € | -26.0% | 472,1 k € | +1.5% | 465,2 k € | -5.8% | 493,8 k € | +5.7% | 467,4 k € | +19.3% | 391,6 k € | +191% | 134,4 k € | +3.7% | 129,6 k € | +6.0% | 122,2 k € |
| Net result | 382,1 k € | +27.0% | 300,9 k € | -2.7% | 309,3 k € | +34.5% | 230 k € | +35.6% | 169,6 k € | +19.3% | 142,2 k € | -8.6% | 155,6 k € | +3.5% | 150,4 k € | -22.8% | 194,8 k € | -28.0% | 270,5 k € | -9.3% | 298,2 k € | -9.3% | 328,9 k € | +7.7% | 305,4 k € | +21.3% | 251,8 k € | +176% | 91,1 k € | +8.5% | 84 k € | +4.2% | 80,6 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||
| Equity | 1,1 M € | -13.0% | 1,2 M € | +13.8% | 1,1 M € | +17.7% | 907,3 k € | +4.0% | 872 k € | -10.4% | 972,9 k € | +16.9% | 832,3 k € | +22.7% | 678,3 k € | -10.1% | 754,5 k € | +34.8% | 559,7 k € | +43.8% | 389,2 k € | +46.3% | 266 k € | -65.8% | 777,1 k € | +50.4% | 516,7 k € | +95.1% | 264,9 k € | +51.0% | 175,4 k € | +88.6% | 93 k € |
| Total assets | 2,6 M € | +21.6% | 2,1 M € | +8.5% | 2 M € | +3.6% | 1,9 M € | -4.3% | 2 M € | +3.1% | 1,9 M € | +1.9% | 1,9 M € | +2.7% | 1,8 M € | +1.4% | 1,8 M € | +1.4% | 1,8 M € | +59.1% | 1,1 M € | -6.7% | 1,2 M € | -7.8% | 1,3 M € | +5.2% | 1,2 M € | +244% | 359,5 k € | +22.1% | 294,3 k € | +69.6% | 173,5 k € |
| Cash | 271 k € | +70.2% | 159,2 k € | -5.5% | 168,4 k € | -28.8% | 236,5 k € | +82.7% | 129,4 k € | -11.5% | 146,2 k € | -28.8% | 205,4 k € | -12.5% | 234,7 k € | +17.7% | 199,4 k € | +2.6% | 194,3 k € | -46.4% | 362,5 k € | -25.1% | 483,9 k € | -14.5% | 565,7 k € | +17.9% | 479,6 k € | +173% | 176 k € | +101% | 87,5 k € | +173% | 32,1 k € |
| Debts | 1,5 M € | +67.7% | 899,9 k € | +2.0% | 881,9 k € | -9.8% | 977,4 k € | -10.5% | 1,1 M € | +17.1% | 932,5 k € | -10.5% | 1 M € | -9.1% | 1,1 M € | +10.2% | 1 M € | -13.9% | 1,2 M € | +68.8% | 715,7 k € | -23.0% | 929,3 k € | +81.6% | 511,8 k € | -27.8% | 709 k € | +675% | 91,5 k € | -20.8% | 115,5 k € | +49.6% | 77,2 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 2 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Maban● Active | 1030.175.929 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 08/07/2026 | 17/07/2025 | 11/07/2024 | 03/07/2023 | 08/07/2022 | 09/07/2021 |
| General meeting | 27/06/2026 | 28/06/2025 | 22/06/2024 | 24/06/2023 | 25/06/2022 | 26/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
17 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 27/06/2026 | 08/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 28/06/2025 | 17/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 22/06/2024 | 11/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 24/06/2023 | 03/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 25/06/2022 | 08/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 26/06/2021 | 09/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 27/06/2020 | 22/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 22/06/2019 | 26/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 23/06/2018 | 09/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 24/06/2017 | 19/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 25/06/2016 | 05/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 27/06/2015 | 29/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 28/06/2014 | 08/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 18/03/2013 | 23/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 23/06/2012 | 27/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 25/06/2011 | 06/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 26/06/2010 | 01/07/2010 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates08/05/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DOEL - ONTSLAGEN - BENOEMINGEN
- Capital / shares02/05/2018KAPITAAL - AANDELEN
- Registered office08/05/2017MAATSCHAPPELIJKE ZETEL
- Capital / shares29/11/2013KAPITAAL - AANDELEN
- Registered office23/01/2012BENAMING - MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other15/10/2008RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025382,1 k €↑
- 2024Annual accounts 2024300,9 k €↓
- 2023Annual accounts 2023309,3 k €↑
- 2022Annual accounts 2022230 k €↑
- 2022Name changeGHANAB
- 2021Annual accounts 2021169,6 k €↑
- 2021Name changeDR. GHILLEMIJN - DR. MEERSSCHAERT
- 2020Annual accounts 2020142,2 k €↓
- 2019Annual accounts 2019155,6 k €↑
- 2018Annual accounts 2018150,4 k €↓
- 2017Annual accounts 2017194,8 k €↓
- 2016Annual accounts 2016270,5 k €↓
- 2015Annual accounts 2015298,2 k €↓
- 2014Annual accounts 2014328,9 k €↑
- 2013Annual accounts 2013305,4 k €↑
- 2012Annual accounts 2012251,8 k €↑
- 2011Annual accounts 201191,1 k €↑
- 2011Name changeDr. Ghillemijn, Gastro-Enterologie - Dr. Meersschaert, Oftalmologie
- 2010Annual accounts 201084 k €↑
- 2009Annual accounts 200980,6 k €
- 2009Name changeDR. GHILLEMIJN
- 07/10/2008IncorporationPrivate limited company